Journal article
A role for surgery in the treatment of relapsed Hodgkin lymphoma
Abstract
Treatment of Hodgkin lymphoma (HL) has advanced over time, rendering a fatal disease now largely curable. Multiagent chemotherapy regimens, hematopoietic stem cell transplantation, and radiotherapy are the mainstays of care. Surgical intervention is rarely indicated other than for biopsy at diagnosis. However, for patients with recurrent relapsed HL isolated to one anatomical location, refractory to all other therapy, there may be a beneficial …
Authors
Fahy AS; Kong I; Weitzman S; Dix D; Baruchel S; Gerstle JT
Journal
Pediatric Blood & Cancer, Vol. 66, No. 1,
Publisher
Wiley
Publication Date
January 2019
DOI
10.1002/pbc.27402
ISSN
1545-5009